Most recent
-
10 Jan 2012: Bank's house broker says selling US business could add up to 12p a share to RBS, or £13bn
-
9 Jan 2012: GlaxoSmithKline presses ahead with regulatory approval for lung drug Relovair, while Astra confirms guidance after error
-
-
6 Jan 2012: BarCap analyst estimates further impairment charges on top of £100bn taken over past four years
-
5 Jan 2012: Chipmaker climbs nearly 3% after upbeat broker note, but concerns over Italy send markets lower
-
4 Jan 2012: Mixed debt auctions and heavily discounted Unicredit cash call spook investors, with Hungary also in focus
-
-
28 Dec 2011: Department of Justice legal opinion offers new hope for online gaming groups, as blue-chips rise gradually
-
23 Dec 2011: Leading shares move higher, marking a gain for the month although banks miss out on the rally
-
22 Dec 2011: Ahead of GDP figures, investors regain their optimism, with banks leading the way
-
-
21 Dec 2011: Euphoria over ECB loan fades, but Lloyds leads banks higher
-
21 Dec 2011: Banks boosted by hopes of cheap loans from ECB, as Santa rally continues
-
20 Dec 2011: Markets shake off eurozone worries in light trading, while luxury goods group says it may renegotiate contract with Interparfums
-
20 Dec 2011: AstraZeneca says two drugs did badly in clinical trials, while leading shares uncertain as eurozone crisis continues
1-15 of 1570 for Barclays